KPLTW vs TECH · rev $247.2M vs P/E 65, rev $1.22B
Katapult Holdings Equity Warrants Exp 09 June 2026 (KPLTW) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Katapult Holdings Equity Warrants Exp 09 June 2026 (KPLTW) common stock listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported KPLTW revenue for 2024-12-31 was $247.2M. Net income was -$25.9M. Revenue was up 11.6% from 2023-12-31 to 2024-12-31. KPLTW currently screens at market cap $327.1M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
KPLTW currently screens at market cap $327.1M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the KPLTW and TECH stock pages for the full models.
Not investment advice.